Provider
QP90-21 Update for New to Market Medical Drugs: Tezepelumab, Faricimab, and Ranibizumab Injection (Susvimo implant)
Program effective Date: Nov 10, 2021
Program effective Date: Nov 10, 2021
Program effective Date: Nov 10, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Nov 01, 2021